The Dapsone Hypersensitivity Syndrome revisited: A potentially fatal multisystem disorder with prominent hepatopulmonary manifestations

Journal of Occupational Medicine and Toxicology

Volumn 1, Issue 1, 2006, Pages

  Kosseifi, Semaan G ^a   Guha, Bhuvana ^a   Nassour, Dima N ^a   Chi, David S ^a   Krishnaswamy, Guha ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAPODA;

EID: 34248180008     PISSN: None     EISSN: 17456673     Source Type: Journal    
DOI: 10.1186/1745-6673-1-9     Document Type: Review

References (30)

1. Zhu YI, Stiller MJ: Dapsone and sulfones in dermatology: over-view and update. J Am Acad Dermatol 2001, 45:420-434.
2. Singletary EM, Rochman AS, Bodmer JC, Holstege CP: Envenomations I. Med Clin North Am 2005, 89:1195-1224.
3. Leslie KS, Gaffney K, Ross CN, Ridley S, Barker TH, Garioch JJ: A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. Clin Exp Dermatol 2003, 28:496-498.
4. Pavithran K, Bindu V: Dapsone syndrome: hepatitis-B infection a risk factor for its development? Int J Lepr Other Mycobact Dis 1999, 67:171-172.
5. Knowles SR, Shapiro LE, Shear NH: Reactive metabolites and adverse drug reactions: clinical considerations. Clin Rev Allergy Immunol 2003, 24:229-238.
6. Rao PN, Lakshmi TS: Increase in the incidence of dapsone hypersensitivity syndrome-an appraisal. Lepr Rev 2001, 72:57-62.
7. Christiansen J, Tegner E, Irestedt M: Dapsone hypersensitivity syndrome in a patient with cutaneous lupus erythematosus. Acta Derm Venereal 1999, 79:482.
8. Reeve PA, Ala J, Hall JJ: Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. J Trop Med Hyg 1992, 95:266-270.
9. Itha S, Kumar A, Dhingra S, Choudhuri G: Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gostroenterol 2003, 3:21.
10. Camus P, Bonniaud P, Fanton A, Camus C, Baudaun N, Foucher P: Drug-induced and iatrogenic infiltrative lung disease 8. Clin Chest Med 2004, 25:479-519, vi.
11. Begbie S, Burgess KR: Maloprim-induced pulmonary eosinophilia. Chest 1993, 103:305-306.
12. Janier M, Guillevin L, Badillet G: Pulmonary eosinophilia associated with dapsone. Lancet 1994, 343:860-861.
13. Arunthathi S, Raju S: Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations-an unusual encounter-a case report. Acta Leprol 1998, 11:3-5.
14. Jaffuel D, Lebel B, Hillaire-Buys D, Pene J, Godard P, Michel FB, Blayac JP, Bousquet J. Demolyi P: Eosinophilic pneumonia induced by dapsone. BMJ 1998,317:181.
15. Davidson AC, Bateman C, Shovlin C, Marrinan M, Burton GH, Cameron IR: Pulmonary toxicity of malaria prophylaxis. BMJ 1988, 297:1240-1241.
16. Tobin-D'Angelo MJ, Hoteit MA, Brown KV, Ray SM, King MD: Dapsone-induced hypersensitivity pneumonitis mimicking Pneumocystis carinii pneumonia in a patient with AIDS. Am J Med Sci 2004, 327:163-165.
17. Corp CC, Ghishan FK: The sulfone syndrome complicated by pancreatitis and pleural effusion in an adolescent receiving dapsone for treatment of acne vulgaris. J Pediatr Gastroenterol Nutr 1998, 26:103-105.
18. Mery L, Dega H, Prost C, Dubertret L: [Dapsone-induced sensory peripheral neuropathy]. Ann Dermatol Venereal 2003, 130:447-449.
19. Fine JD, Katz SI, Donahue MJ, Hendricks AA: Psychiatric reaction to dapsone and sulfapyridine I. J Am Acad Dermatol 1983, 9:274-275.
20. Hoffbrand BI: Dapsone and renal papillary necrosis I. Br Med J 1978, 1:78.
21. Volcheck GW: Clinical evaluation and management of drug hypersensitivity 5. Immunol Allergy Clin North Am 2004, 24:357-71, v.
22. McKenna JK, Leiferman KM: Dermatologie drug reactions 2. Immunol Allergy Clin North Am 2004, 24:399-423, vi.
23. McKenna KE, Robinson J: The dapsone hypersensitivity syndrome occurring in a patient with dermatitis herpetiformis. Br J Dermatol 1997, 137:657-658.
24. Prussick R, Shear NH: Dapsone hypersensitivity syndrome. J Am Acad Dermatol 1996, 35:346-349.
25. Krishnaswamy G: Treatment strategies for bronchial asthma: an update 33. Hosp Pract (Off Ed) 2001, 36:25-35.
26. Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G: The role of human mast cell-derived cytokines in eosinophil biology 14. J Interferon Cytokine Res 2004, 24:271-281.
27. Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids - New mechanisms for old drugs I. New England Journal of Medicine 2005, 353:1711-1723.
28. Fitzgerald SM, Chi DS, Hall HK, Reynolds SA, Aramide O, Lee SA, Krishnaswamy G: GM-CSF induction in human lung fibroblasts by IL-I beta, TNF-alpha, and macrophage contact 24. J Interferon Cytokine Res 2003, 23:57-65.
29. Chogle A, Nagral A, Soni A, Agale S, Jamadar Z: Dapsone hypersensitivity syndrome with coexisting acute hepatitis E. Indian J Gastroenterol 2000, 19:85-86.
30. Gupta A, Eggo MC, Uetrecht JP, Cribb AE, Daneman D, Rieder MJ, Shear NH, Cannon M, Spielberg SP: Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides I. Clin Pharmacol Ther 1992, 51:56-67.